Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Artigo em Francês | AIM (África) | ID: biblio-1363037

RESUMO

Introduction : L'infection par le virus de l'immunodéficience humaine au (VIH) est une infection chronique caractérisée par la destruction progressive du système immunitaire par le virus. L'objectif de cette étude était de décrire le profil clinique, immunologique et virologique des personnes vivant avec le VIH et suivies au CHU Départemental Ouémé-Plateau de Porto-Novo. Méthodes : Il s'agissait d'une étude transversale et descriptive couvrant la période du 1er février 2016 au 1er mai 2016. Il a été procédé à un recrutement exhaustif de toutes les personnes vivant avec le VIH suivies en ambulatoire ou hospitalisées dans le Service de Médecine Interne du CHUD-OP, âgées d'au moins 15 ans et ayant donné leur consentement éclairé. Résultats : Au total 301 patients ont été inclus. L'âge moyen était de 42 ans ± 10,3 ans, avec des extrêmes de 19 ans et 74 ans. Les tranches d'âge les plus représentées étaient celle des 35 à 45 ans (118 patients soit 39,2%) et celle des 25 à 35 ans (72 patients soit 23,9%). Cette population était majoritairement féminine (73,1 %), soit une sex-ratio de 0,37. Les enquêtés, dans 79,4 %, étaient en couple. Le stade clinique 3 de l'OMS était prédominant (47,8%). Parmi les pathologies associées, l'hypertension artérielle était la plus fréquente (18.6%). Parmi ces patients, 300 (99,7 %) étaient porteurs de VIH 1. La charge virale a été réalisée chez 177 (58,8 %) patients et s'est révélée indétectable chez 117 patients soit 66,1 % des cas. La numération des CD4 a été réalisée chez 298 (99 %). Le nombre médian des CD4 était de 350 (Q1=206 ; Q3=504). Parmi les 301 PVVIH, 291 (96,68 %) étaient sous traitement antirétroviral. Conclusion : Cette population de personnes vivant avec le VIH est jeune et consulte tardivement


Introduction : Human immunodeficiency virus (HIV) infection is a chronic infection characterized by the progressive destruction of the immune system by the virus. The objective of this study was to describe the clinical, immunological and virological profile of people living with HIV and monitored at the Ouémé-Plateau Departmental University Hospital in Porto-Novo. Methods: This was a cross-sectional and descriptive study covering the period from February 1, 2016 to May 1, 2016. An exhaustive recruitment was carried out of all people living with HIV followed on an outpatient basis or hospitalized in the Service of Internal Medicine of the CHUD-OP, at least 15 years old and having given their informed consent. Results: A total of 301 patients were included. The mean age was 42 ± 10.3 years, with extremes of 19 and 74 years. The most represented age groups were that of 35 to 45 years (118 patients or 39.2%) and that of 25 to 35 years (72 patients or 23.9%). This population was predominantly female (73.1%), i.e. a sex ratio of 0.37. The respondents, in 79.4%, were in a relationship. WHO clinical stage 3 was predominant (47.8%). Among the associated pathologies, arterial hypertension was the most common (18.6%). Of these patients, 300 (99.7%) were carriers of HIV 1. Viral load was achieved in 177 (58.8%) patients and was undetectable in 117 patients, or 66.1% of cases. CD4 counts were performed in 298 (99%). The median CD4 count was 350 (Q1 = 206; Q3 = 504). Among the 301 PLHIV, 291 (96.68%) were on antiretroviral therapy. Conclusion: This population of people living with HIV is young and consults late.


Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Idoso , Infecções por HIV , Infecções Oportunistas Relacionadas com a AIDS , Carga Viral , Diagnóstico , Sistema Imunitário
2.
Med Sante Trop ; 27(2): 190-194, 2017 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-28655682

RESUMO

Distal sensory polyneuropathy (DSP) is the most frequent neurological complication among HIV patients, and its risk increases with use of highly active antiretroviral therapy (HAART). We aimed to assess the prevalence of DSP and the factors associated with it among HIV-infected outpatients treated at Parakou University Hospital. This cross-sectional study took place from April 15 to July 15, 2011, and included 262 patients. All patients underwent a neurological examination by two neurologists with training and clinical experience in these examinations and in the Brief Peripheral Neuropathy Screening (BPNS), which was the primary tool used here. Data from nutritional status (body mass index: BMI), social and demographic information, HAART status, and CD4 count were recorded. The factors associated with DSP were studied with multivariate analysis, using a logistic regression model and a significance level of 0.05. The study included 60 men (22.9 %). Patients' ages ranged from 16 to 74 years and averaged 36.8±10 years. All patients but one patient were infected by HIV type 1 only; that one was coinfected by types 1 and 2. The mean BMI was 22.5+/-4.2 kg/m2. In all, 213 (81.3 %) received HAART, and the mean CD4 count was 355.0 cells/mm3+/-236.1. The prevalence of DSP was 42.4 %. The factors associated with it on univariate analysis were age, marital status, HAART status, duration of HIV infection, and duration of HAART. Only advanced age (OR 1.8, 95 % CI 1.1-5.3) and HAART use (OR 2.3, 95 % CI 1.5-4.9) were associated with DSP in the multivariate analysis. The main symptoms were paresthesia (numbness:75.7%; burning: 39.6%; pins and needles sensation 32.4 %) and pain (23.4 %). Vibration perception at the toes was missing or reduced for 84.4 %. According to the sensory symptoms grade, 93.7 % of patients were classified in Grades 2 or 3. This study showed that the prevalence of DSP is high and that it is associated with age and HAART.


Assuntos
Infecções por HIV/epidemiologia , Polineuropatias/diagnóstico , Polineuropatias/epidemiologia , Adolescente , Adulto , Fatores Etários , Idoso , Terapia Antirretroviral de Alta Atividade/efeitos adversos , Benin/epidemiologia , Estudos Transversais , Feminino , Hospitais Universitários , Humanos , Masculino , Pessoa de Meia-Idade , Índice de Gravidade de Doença , Adulto Jovem
3.
Med Trop (Mars) ; 71(6): 634-5, 2011 Dec.
Artigo em Francês | MEDLINE | ID: mdl-22393642

RESUMO

Although salmonellosis is a common endemo-epidemic disease in Benin, there is a paucity of data about it. The purpose of this cross-sectional study was to determine the incidence of major salmonellosis requiring hospitalizaton and to describe its epidemiological, clinical, and serologic features as well as treatment and outcome. Consecutive cases observed at the Medical Department of Parakou University Hospital in Benin between January 1, 2005 and December 31 2007 were included. Salmonellosis was defined on the basis of clinical and serological criteria. Among the 2,520 patients hospitalized during the study period, salmonellosis was diagnosed in 135 (5.4% [95% CI 4.5%-6.3%]). Highest incidences were observed in January, July, October and November. The main symptoms were headache, fever, fatigue and abdominal pain. The Salmonella typhi serotype was identified in 94.8% of patients. Two patients presented co-infection, i.e., Salmonella typhi with paratyphi A in one case and Salmonella typhi with paratyphi B in the other. Fluoroquinolones were used for treatment in 79.3% of patients. Outcome was favorable in 62.2%. The main complications were,typhoid digestive perforation in 11.1%, and gastrointestinal bleeding in 8.1%. The mortality rate was 4.4% (n=6). These data are consistent with previous reports in the literature and confirm the frequency and severity of salmonellosis in Benin.


Assuntos
Infecções por Salmonella/diagnóstico , Infecções por Salmonella/epidemiologia , Infecções por Salmonella/terapia , Adolescente , Adulto , Idoso , Benin/epidemiologia , Estudos Transversais , Diagnóstico Tardio/estatística & dados numéricos , Feminino , Hospitalização/estatística & dados numéricos , Humanos , Tempo de Internação/estatística & dados numéricos , Masculino , Pessoa de Meia-Idade , Prognóstico , Infecções por Salmonella/sangue , Testes Sorológicos , Adulto Jovem
4.
Ann Cardiol Angeiol (Paris) ; 59(1): 40-3, 2010 Feb.
Artigo em Francês | MEDLINE | ID: mdl-19962690

RESUMO

Right atrial myxoma is a heart benignant tumor characterized by an important clinical polymorphism. We report a case of a 30-year-old female with a diagnosis of a big right atrial myxoma. The diagnosis has been done by transthoracic echocardiography which showed an important tumorous mass in the right atrium. It was moving, inhomogeneous and takes over the whole of right atrium cavity. The surgical excision of the tumor has been done under extracorporal circulation. The patient died after a second intervention for tricuspid failure.


Assuntos
Átrios do Coração , Neoplasias Cardíacas/diagnóstico , Mixoma/diagnóstico , Disfunção Ventricular Direita/diagnóstico , Disfunção Ventricular Direita/etiologia , Adulto , Ecocardiografia , Eletrocardiografia , Evolução Fatal , Feminino , Átrios do Coração/patologia , Átrios do Coração/cirurgia , Neoplasias Cardíacas/patologia , Neoplasias Cardíacas/cirurgia , Humanos , Mixoma/patologia , Mixoma/cirurgia , Complicações Pós-Operatórias/diagnóstico , Complicações Pós-Operatórias/cirurgia , Reoperação , Insuficiência da Valva Tricúspide/diagnóstico , Insuficiência da Valva Tricúspide/patologia , Insuficiência da Valva Tricúspide/cirurgia , Disfunção Ventricular Direita/patologia , Disfunção Ventricular Direita/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA